Beta
243457

Modulatory effect of zeolite in an experimental rat model of Alzheimer's disease

Article

Last updated: 04 Jan 2025

Subjects

-

Tags

-

Abstract

In our study, the potential modulatory effect of zeolite on aluminum chloride used to induce Alzheimer's disease was investigated. Rats were divided into four groups (control group, aluminum chloride group, aluminum chloride and zeolite group, zeolite group). Aluminum chloride treatment characterized by decreasing latency for animals to step into the dark section in passive avoidance test, increasing escape latency to climb the platform and spent significantly less time in the defined part in Morris water maze test .Also, increase acetylcholinesterase content, Amyloid beta content, oxidative stress markers and inflammatory mediators, also decrease phosphorylated glycogen synthase kinase 3 beta content ,and increase free cytosolic beta catenin and brain derived neurotrophic factor content (downregulation of Wnt/ β-catenin pathway). Also, in histopathological examination shows pyknosis and degeneration in the neurons of cerebral cortex, hippocampus and striatum indicating induction of Alzheimer's disease. On the other hand, Treatment with zeolite increases latency for animals to step to the dark section of passive avoidance test, decreasing escape latency and spent significantly more time in the defined part in Morris water maze test .Also, decrease acetylcholinesterase content, Amyloid beta content, oxidative stress markers and the release of inflammatory mediators, increase phosphorylated glycogen synthase kinase 3 beta content, and decrease cytosolic free beta catenin and brain derived neurotrophic factor content (upregulation of Wnt/ β-catenin signaling pathway) decreases pyknosis and degeneration in histopathological examination indicating zeolite attenuation of aluminum chloride induction of Alzheimer's disease .

DOI

10.21608/aijpms.2022.107355.1097

Keywords

Alzheimer’s disease, Zeolite, Acetylcholinesterase, Oxidative Stress, Inflammatory mediators, brain derived neurotrophic factor, glycogen synthase kinase 3 beta, (Wnt/ β-catenin signaling pathway)

Authors

First Name

Aya

Last Name

Omran

MiddleName

A

Affiliation

Department of Pharmacology, Egyptian Drug Authority (EDA), formerly NODCAR, Giza, Egypt.

Email

aya.shafi.omran@gmail.com

City

cairo

Orcid

-

First Name

Eman

Last Name

Mohamed

MiddleName

A

Affiliation

Department of Pharmacology and Toxicology, Faculty of Pharmacy (Girls), Al-Azhar university, Cairo, Egypt.

Email

emanabdelwahed@yahoo.com

City

Cairo

Orcid

0000-0002-3795-978X

First Name

Ola

Last Name

Abd Elraouf

MiddleName

M

Affiliation

Department of Pharmacology, Egyptian Drug Authority (EDA), formerly NODCAR, Giza, Egypt.

Email

dr.ola.raouf@gmail.com

City

Giza

Orcid

-

First Name

Gehan

Last Name

Georgy

MiddleName

S

Affiliation

Department of Pharmacology, Egyptian Drug Authority (EDA), formerly NODCAR, Giza, Egypt.

Email

gehan_gorgy11@hotmail.com

City

Giza

Orcid

-

First Name

Amany

Last Name

Balah

MiddleName

I

Affiliation

Department of Pharmacology and Toxicology, Faculty of Pharmacy (Girls), Al-Azhar university, Cairo, Egypt.

Email

amanyibrahim99@yahoo.com

City

Cairo

Orcid

-

Volume

2

Article Issue

2

Related Issue

34881

Issue Date

2022-06-01

Receive Date

2021-11-23

Publish Date

2022-06-01

Page Start

105

Page End

115

Print ISSN

2735-4598

Online ISSN

2735-4601

Link

https://aijpms.journals.ekb.eg/article_243457.html

Detail API

https://aijpms.journals.ekb.eg/service?article_code=243457

Order

11

Type

Original research articles

Type Code

1,562

Publication Type

Journal

Publication Title

Azhar International Journal of Pharmaceutical and Medical Sciences

Publication Link

https://aijpms.journals.ekb.eg/

MainTitle

Modulatory effect of zeolite in an experimental rat model of Alzheimer's disease

Details

Type

Article

Created At

23 Jan 2023